View Cart  

Presubmissions Draft Guidance Due Soon, Industry Best Practice Paves Way for Now

A new draft guidance outlining expectations for presubmission meetings with the U.S. Food and Drug Administration (FDA) is expected in the next few months, regulators said during a March 5 Regulatory Affairs Professionals Society meeting.

To View This Article:


Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00